Association between Lipoprotein(a) concentration and adverse cardiac events in patients with coronary artery disease: An observational cohort study
Document Type
Article
Publication Title
Indian Heart Journal
Abstract
This prospective study investigated the association between lipoprotein (a) [Lp(a)] levels and adverse cardiac events in patients undergoing percutaneous coronary intervention (PCI) for coronary artery disease. Among 600 patients, 79.16 % were male. Kaplan Meier analysis revealed significantly higher incidence rates of cardiac death, major adverse cardiac events, myocardial infarction, revascularization and stroke in patients with elevated Lp(a) (≥30 mg/dL). The Cox Regression model identified Lp(a) ≥30 mg/dL as a significant risk factor for adverse events (HR: 4.2920; 95%CI: 2.58–7.120; p < 0.05). Elevated Lp(a) levels were associated with an increased risk of adverse cardiac events in coronary artery disease patients undergoing PCI.
First Page
197
Last Page
201
DOI
10.1016/j.ihj.2024.06.001
Publication Date
5-1-2024
Recommended Citation
Amin, Navaneeth; Devasia, Tom; Kamath, Shobha Ullas; and Paramasivam, Ganesh, "Association between Lipoprotein(a) concentration and adverse cardiac events in patients with coronary artery disease: An observational cohort study" (2024). Open Access archive. 10417.
https://impressions.manipal.edu/open-access-archive/10417
